| Mon, Nov 30, 2009 | | | Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz at TheStreet.com (Mon 11:16am)
| | | UPDATE - FDA holds up Merck KGaA's multiple sclerosis pill at Reuters (Mon 9:58am)
| | Fri, Nov 27, 2009 | | | Biotech Bargains for Your Portfolio at Motley Fool (Fri, Nov 27)
| | Thu, Nov 26, 2009 | | | Financing Drug Discovery: Recent Deals at Seeking Alpha (Thu, Nov 26)
| | Wed, Nov 25, 2009 | | | Cancer drug preserves insulin cells in diabetes at Reuters (Wed, Nov 25)
| | | Still Enjoying Those Acquisitions, Pfizer? at Motley Fool (Wed, Nov 25)
| | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc. GlobeNewswire (Wed, Nov 25)
| | Mon, Nov 23, 2009 | | | [$$] Fitz Bits: Wait for a Retest in Ford at RealMoney by TheStreet.com (Mon, Nov 23)
| | | A Big Upgrade for Allos Therapeutics at Motley Fool (Mon, Nov 23)
| | | Icahn Makes Big Moves in Healthcare Stocks Indie Research (Mon, Nov 23)
| | Sun, Nov 22, 2009 | | | Spectrum Pharma: Zevalin Sales Ramp Up at Seeking Alpha (Sun, Nov 22)
| | Fri, Nov 20, 2009 | | | UPDATE - HealthCor slams Biogen CEO for outsize pay package at Reuters (Fri, Nov 20)
| | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Wall Street Transcript (Fri, Nov 20)
| | | Biogen's Rituxan Label Expansion Delayed Zacks.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | | This Stock Is a Train Wreck at Motley Fool (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | | Genentech, Biogen get FDA request on Rituxan AP (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | | [$$] Activity Jumps in Biotech and Drug Firms at The Wall Street Journal Online (Tue, Nov 17)
| | | Genzyme's Termeer: Worst Biotech CEO of '09 at TheStreet.com (Tue, Nov 17)
| | Fri, Nov 13, 2009 | | | Abbott: Brave or Stupid? at Motley Fool (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | | Wider Loss for Alnylam Zacks.com (Thu, Nov 12)
| Add BIIB News to My Yahoo!:

| |
|